SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Mar. 31, 2019

Accounting Policies [Abstract]

Summary of Revenue by Solution

The components of revenues by solution which reflect a disaggregation of revenue by contract type are as follows (dollar amounts in thousands):

	Three-Months Ended March 31,
	2019		% Total		2018(2)		% Total
REVENUES BY SOLUTION:
Mailbacks	$	4,577	48.4	%	$	4,721	50.1	%
Route-based pickup services	2,259		23.9	%	1,888		20.0	%
Unused medications	1,705		18.0	%	1,832		19.4	%
Third party treatment services	26		0.3	%	44		0.5	%
Other (1)	884		9.4	%	942		10.0	%
Total revenues	$	9,451	100.0	%	$	9,427	100.0	%
	Nine-Months Ended March 31,
	2019		% Total		2018(2)		% Total
REVENUES BY SOLUTION:
Mailbacks	$	18,223	56.8	%	$	16,982	56.2	%
Route-based pickup services	6,465		20.1	%	5,479		18.1	%
Unused medications	4,694		14.6	%	4,321		14.3	%
Third party treatment services	206		0.6	%	815		2.7	%
Other (1)	2,550		7.9	%	2,632		8.7	%
Total revenues	$	32,138	100.0	%	$	30,229	100.0	%

(1) The Company’s other products include IV poles, accessories, containers, asset return boxes and other miscellaneous items with single performance obligations.

(2) Certain prior year amounts have been reclassified to conform to current year presentation.

Schedule of Impact of New Accounting Guidance

The impact of adopting the new accounting guidance on the Company's condensed consolidated balance sheet as of March 31, 2019 was as follows (in thousands):

	March 31, 2019
	As Reported			Adjustments			Balance Without Adoption
Current contract asset	$	236		$	(236	)	$	—
Prepaid and other current assets	839			(33		)	806
Total current assets	16,548			(269		)	16,279
Total assets	34,035			(269		)	33,766
Current contract liability(1)	2,110			11			2,121
Total current liabilities	6,642			11			6,653
Contract liability, net of current portion(1)	387			—			387
Total liabilities	8,496			11			8,507
Accumulated deficit	(1,995		)	(280		)	(2,275		)
Total stockholders' equity	25,539			(280		)	25,259
Total liabilities and stockholders' equity	$	34,035		$	(269	)	$	33,766

(1): Prior period contract liabilities were referred to as deferred revenue.

The impact of adopting the new accounting guidance on the Company's condensed consolidated statement of operations for the three and nine months ended March 31, 2019 was as follows (in thousands):

	Three Months Ended March 31, 2019								Nine-Months Ended March 31, 2019
	As Reported			Adjustments		Balance Without Adoption			As Reported			Adjustments		Balance Without Adoption
Revenues	$	9,451		$	105	$	9,556		$	32,138		$	209	$	32,347
Cost of revenues	7,416			54		7,470			22,760			118		22,878
Gross profits	2,035			51		2,086			9,378			91		9,469
Selling, general and administrative	2,901			11		2,912			8,886			33		8,919
Operating income	(1,073		)	40		(1,033		)	(121		)	58		(63		)
Net loss	$	(1,125	)	$	40	$	(1,085	)	$	(276	)	$	58	$	(218	)